Home » Authors » Nuala Moran

Articles by Nuala Moran

CAT Enters Deal For Antibodies Against Two Immunex Targets

May 23, 2001

Isogenica Formed With $3M To Develop Discovery Technology

May 16, 2001

Isogenica Formed With $3M To Develop Discovery Technology

May 16, 2001

Astex Financing Round Raises £22.7 For X-Ray Crystallography

May 9, 2001

Watchdog Finds Insurance Firms Using Non-Approved Gene Tests

May 9, 2001

Astex Financing Round Raises £22.7 For X-Ray Crystallography

May 9, 2001

Watchdog Finds Insurance Firms Using Non-Approved Gene Tests

May 9, 2001

European Industry Burgeoning, Survey Says: Germany Leads

May 2, 2001

Vectura's Financing Bid Gets £10.55M To Fund Four Platforms

May 2, 2001

European Industry Burgeoning, Survey Says: Germany Leads

May 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...